Gladstone Institutional Advisory LLC
Position in GPCR — Structure Therapeutics Inc.
CIK 1766530
Bedminster, NJ
Position in GPCR
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$712,469
New position
Shares Held
13,275
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#115
of 191 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Gladstone Institutional Advisory LLC holds $1,952,269 across 9 Biotechnology names. GPCR ranks #1 (36.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GPCR |
Structure Therapeutics Inc.
This page
|
13,275 | $712,469 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
50,818 | $444,911 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
9,527 | $371,648 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
383 | $238,815 | |
| 5 | GALT |
Galectin Therapeutics Inc
|
23,900 | $110,896 | |
| 6 | AVXL |
Anavex Life Sciences Corp.
|
17,671 | $45,767 | |
| 7 | CRDF |
Cardiff Oncology, Inc.
|
13,000 | $16,900 | |
| 8 | ATYR |
aTYR PHARMA INC
|
11,300 | $6,746 |
All Filings in GPCR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $712,469 | 13,275 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||